WATERTOWN, Mass. (AP) _ EyePoint Pharmaceuticals (EYPT) on Wednesday reported a loss of $10 million in its second quarter.
On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of 35 cents.
The drug delivery technology company posted revenue of $9 million in the period.
EyePoint Pharmaceuticals shares have increased 30% since the beginning of the year. The stock has risen 21% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EYPT at https://www.zacks.com/ap/EYPT
Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News